116 related articles for article (PubMed ID: 16113666)
1. Adoptive transfer of vitiligo after allogeneic peripheral blood stem cell transplant.
Campbell-Fontaine A; Coad JE; Kovach R; Ericson SG
Bone Marrow Transplant; 2005 Oct; 36(8):745-6. PubMed ID: 16113666
[No Abstract] [Full Text] [Related]
2. Angiomatous nodules acquired after allogeneic stem cell transplantation.
Braun-Falco M; Menzel H
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):123-4. PubMed ID: 18181994
[No Abstract] [Full Text] [Related]
3. Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
Neumeister P; Strunk D; Apfelbeck U; Sill H; Linkesch W
Lancet; 2000 Apr; 355(9212):1334-5. PubMed ID: 10776751
[TBL] [Abstract][Full Text] [Related]
4. Wernicke's encephalopathy after allogeneic stem cell transplantation.
Baek JH; Sohn SK; Kim DH; Kim JG; Lee HW; Park SP; Lee KB
Bone Marrow Transplant; 2005 Apr; 35(8):829-30. PubMed ID: 15750604
[No Abstract] [Full Text] [Related]
5. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
Rowe JM
Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451
[TBL] [Abstract][Full Text] [Related]
6. Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia.
Nakaseko C; Sakaida E; Ohwada C; Ozawa S; Takeuchi M; Shimizu N; Cho R; Yokota A; Saito Y; Nishimura M
Ann Hematol; 2007 Jan; 86(1):67-9. PubMed ID: 17021838
[No Abstract] [Full Text] [Related]
7. Severe vulgaris psoriatic patients with acute myelogenous leukaemia and resolution after allogeneic bone marrow transplantation/peripheral blood stem cell transplantation.
He YL; Lu XJ; Qiu JY; Zhu TJ
Chin Med J (Engl); 2005 May; 118(10):861-5. PubMed ID: 15989770
[No Abstract] [Full Text] [Related]
8. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.
Oyekunle AA; Kröger N; Zabelina T; Ayuk F; Schieder H; Renges H; Fehse N; Waschke O; Fehse B; Kabisch H; Zander AR
Bone Marrow Transplant; 2006 Jan; 37(1):45-50. PubMed ID: 16258531
[TBL] [Abstract][Full Text] [Related]
9. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
[TBL] [Abstract][Full Text] [Related]
10. Skin Lesions and Recurrent Fever in Acute Myeloid Leukemia Patient Treated With Allogeneic Stem Cell Transplant.
Yun S; Vincelette ND
JAMA Oncol; 2016 Dec; 2(12):1649-1650. PubMed ID: 27583691
[No Abstract] [Full Text] [Related]
11. Cerebral tuberculosis post stem cell transplant.
Bloor AJ; Mackinnon S
Eur J Haematol; 2006 Nov; 77(5):456. PubMed ID: 16856918
[No Abstract] [Full Text] [Related]
12. Correction of celiac disease after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kline RM; Neudorf SM; Baron HI
Pediatrics; 2007 Oct; 120(4):e1120-2. PubMed ID: 17893186
[TBL] [Abstract][Full Text] [Related]
13. [Second nonmyeloablative allogeneic peripheral blood stem cell transplantation with more immunosuppressive conditioning regimen for the late graft failure of the patient with acute myeloid leukemia].
Tachikawa Y; Abe Y; Choi I; Ohtsuka R; Nagasawa E; Shibata K; Nishimura J; Nawata H; Muta K
Fukuoka Igaku Zasshi; 2005 Nov; 96(11):378-82. PubMed ID: 16502857
[TBL] [Abstract][Full Text] [Related]
14. Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients.
Muetherig A; Christopeit M; Müller LP; Grothe W; Weber T; Theurich S; Behre G
Bone Marrow Transplant; 2007 Mar; 39(5):315-6. PubMed ID: 17311086
[No Abstract] [Full Text] [Related]
15. Late onset of EBV-driven PTLD/Burkitt lymphoma/leukemia in a patient 10 years after allogeneic stem cell transplant for AML.
Huang Q; Popplewell L; Lu Y; Slovak ML; Forman SJ
Bone Marrow Transplant; 2010 Jan; 45(1):191-4. PubMed ID: 19430500
[No Abstract] [Full Text] [Related]
16. Peptide vaccines for patients with acute myeloid leukemia.
Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A
Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762
[TBL] [Abstract][Full Text] [Related]
17. Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant.
Shaw BE; Russell NH
Bone Marrow Transplant; 2008 Mar; 41(5):495-503. PubMed ID: 17952130
[TBL] [Abstract][Full Text] [Related]
18. The effect of graft-versus-host disease on skin endothelial and epithelial cell chimerism in stem-cell transplant recipients.
Willemze AJ; Bakker AC; von dem Borne PA; Bajema IM; Vossen JM
Transplantation; 2009 Apr; 87(7):1096-101. PubMed ID: 19352133
[TBL] [Abstract][Full Text] [Related]
19. Maximum supportive care, standard conditioning and allogeneic stem cell transplantation for elderly patients with acute myelogenous leukemia.
Petersen FB; Ford CD
Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S7-9. PubMed ID: 19561415
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
